HCW Biologics Future Growth
Future criteria checks 0/6
HCW Biologics's earnings are forecast to decline at 5% per annum while its annual revenue is expected to grow at 77.6% per year. EPS is expected to grow by 8.5% per annum.
Key information
-5.0%
Earnings growth rate
8.5%
EPS growth rate
| Biotechs earnings growth | 21.3% |
| Revenue growth rate | 77.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Apr 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -38 | N/A | N/A | 1 |
| 12/31/2025 | N/A | -30 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -24 | N/A | N/A | 1 |
| 12/31/2023 | 3 | -25 | -29 | -23 | N/A |
| 9/30/2023 | 3 | -20 | -25 | -22 | N/A |
| 6/30/2023 | 4 | -19 | -31 | -19 | N/A |
| 3/31/2023 | 4 | -18 | -23 | -12 | N/A |
| 12/31/2022 | 7 | -15 | -21 | -10 | N/A |
| 9/30/2022 | 5 | -13 | -20 | -10 | N/A |
| 6/30/2022 | 4 | -12 | -13 | -13 | N/A |
| 3/31/2022 | 3 | -12 | -11 | -11 | N/A |
| 12/31/2021 | N/A | -13 | -11 | -11 | N/A |
| 9/30/2021 | 4 | -8 | -11 | -11 | N/A |
| 6/30/2021 | 4 | -8 | -9 | -9 | N/A |
| 3/31/2021 | 4 | -8 | -10 | -10 | N/A |
| 12/31/2020 | 4 | -7 | -11 | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HCWB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: HCWB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: HCWB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: HCWB is forecast to have no revenue next year.
High Growth Revenue: HCWB is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HCWB's Return on Equity is forecast to be high in 3 years time